DashboardAll companies
Run this on your own research
Healthcare · Medical Devices

Stryker Corporation

SYKNYSE$307.15+$0.07 (+0.02%)Market closed

Price Chart

Daily

Key facts

Market Cap
$117.79B
P/E
36.2x
P/B
5.24x
ROE
15.1%

Stryker Corporation

Healthcare · Medical Devices · FY 2025

Stryker Corporation is a global leader in the medical technology sector, specializing in the design, manufacture, and distribution of innovative healthcare products. The company operates through two primary segments: MedSurg and Neurotechnology, and Orthopaedics and Spine. Its offerings include surgical equipment, advanced surgical navigation and endoscopic systems, patient handling and emergency medical equipment, as well as a range of neurotechnology products used for minimally invasive procedures such as stroke interventions and complex cranial surgeries. In orthopaedics, Stryker provides implants for hip and knee replacements, spinal injury therapies, and products for trauma and extremity surgeries. Serving customers in approximately 75 countries, Stryker supports hospitals, physicians, and healthcare facilities worldwide, impacting over 150 million patients annually. Founded in 1941 and headquartered in Portage, Michigan, the company holds over 14,000 patents and invests heavily in research and development, reinforcing its strong presence and influence within the global healthcare industry.

CEO
Mr. Kevin A. Lobo
Employees
53,000

Company Statistics

Valuation

P/E
36.2x
P/B
5.24x
P/S
4.67x
EV/EBITDA
19.9x
P/FCF
27.4x

Margins

Gross
64.0%
EBITDA
25.8%
Operating
20.1%
Pre-Tax
18.0%
Net
12.9%

Returns

ROA
7.1%
ROE
15.1%
ROIC
11.3%

Growth (CAGR)

Rev 3Yr
10.8%
Rev 5Yr
11.8%
Op Inc 3Yr
18.5%
Net Inc 3Yr
11.2%

Financial Health

Cash & Cash Equivalents
$4.01B
Net Debt
$21.41B
Debt/Equity
113.4%
Interest Cov
—

Profile

Revenue
$25.12B
Shares Out
—
Public markets · Korea, US, Japanalpha-lenz.com · Core by Treasurer
Stryker Corporation (SYK) Stock Forecast 2026 $307.15 — Price, Financials & Analyst Targets | AlphaLenz